In summary, our results reveal that mPGC‐1α significantly inhibits the cGAS/STING axis and reduces inflammation in CI‐AKI, underscoring the potential of targeting this pathway in CI‐AKI management. The gene discussed is STING1; the disease is acute kidney injury.